| COMPANY | SYMBOL | TYPE | PRICE | Shares | Trade Date | UNDERWRITER (S) |
| 1Life Healthcare, Inc. | ONEM | IPO | $14.00-$16.00 | 17.5 million | 1/31/2020 | JP Morgan, Morgan Stanley, Allen & Co., Citigroup, Piper Jaffray, Wells Fargo, William Blair |
| Acceleron Pharma | XLRN | IPO | $13.00-$15.00 | 5.6 million | 9/19/2013 | Citigroup, Leerink Swann, Piper Jaffray |
| Adamas Pharmaceuticals | ADMS | IPO | $16.00-$18.00 | 3 million | 4/10/2014 | Credit Suisse, Piper Jaffray |
| Aimmune Therapeutics, Inc. | AIMT | IPO | $14.00-$16.00 | 10 million | 8/6/2015 | BofA Merrill Lynch, Credit Suisse, Piper Jaffray |
| Amphastar Pharmaceuticals | AMPH | IPO | $10.00-$12.00 | 8 million | 6/25/2014 | Jefferies, BMO Capital Markets, Piper Jaffray |
| Applied Optoelectronics | AAOI | IPO | $13.00-$15.00 | 3.6 million | 9/26/2013 | Raymond James, Piper Jaffray |
| Arcadia Biosciences, Inc. | RKDA | IPO | $13.00-$15.00 | 8.2 million | 5/15/2015 | Credit Suisse, J.P. Morgan, Piper Jaffray |
| Argenx N.V. | ARGX | IPO | Last Trade $18.18 | 5.0 million ADS | 5/18/2017 | Cowen and Company, Piper Jaffray |
| Argos Therapeutics | ARGS | IPO | $13.00-$15.00 | 5.63 million | 2/7/2014 | Piper Jaffray, Stifel, JMP Securities |
| Arsanis, Inc. | ASNS | IPO | $15.00-$17.00 | 4 million | 11/16/2017 | Citigroup, Cowen, Piper Jaffray |
| Arvinas, Inc | ARVN | IPO | $14.00-$16.00 | 7.5 million | 9/27/2018 | Goldman Sachs, Citigroup, Piper Jaffray |
| ASLAN Pharmaceuticals Limited | ASLN | IPO | $8.05-$8.05 | 6 million ADSs | 5/4/2018 | Leerink Partners, Piper Jaffray |
| Audentes Therapeutics, Inc. | BOLD | IPO | $14.00-$16.00 | 5 million | 7/20/2016 | BofA Merrill Lynch, Cowen & Co., Piper Jaffray |
| Avalanche Biotechnologies, Inc. | AAVL | IPO | $13.00-$15.00 | 5.4 million | 7/31/2014 | Jefferies, Cowen & Co., Piper Jaffray |
| Bellicum Pharmaceuticals | BLCM | IPO | $15.00-$17.00 | 7.35 million | 12/18/2014 | Jefferies, Citigroup, Piper Jaffray |
| Bicycle Therapeutics plc | BCYC | IPO | $14.00-$16.00 | 4.33 million | 5/23/2019 | Goldman Sachs, Jefferies, Piper Jaffray |
| Biohaven Pharmaceutical Holding Company Ltd. | BHVN | IPO | $14.00-$16.00 | 9.9 million | 5/4/2017 | Morgan Stanley, Piper Jaffray, Barclays |
| Bluestem Brands, Inc. | BSTM | IPO | Postponed | 10 million | 11/16/2011 | Deutsche Bank Securities, Piper Jaffray |
| Bojangles', Inc. | BOJA | IPO | $15.00-$17.00 | 7.75 million | 5/8/2015 | BofA Merrill Lynch, Wells Fargo Securities, Jefferies, Barclays, Goldman Sachs & Co., Piper Jaffray, William Blair, KeyBanc Capital Markets, RBC Capital Markets |
| Boot Barn Holdings, Inc. | BOOT | IPO | $14.00-$16.00 | 5 million | 10/30/2014 | J.P. Morgan, Piper Jaffray, Jefferies |
| Cara Therapeutics | CARA | IPO | $11.00-$13.00 | 5 million | 1/31/2014 | Stifel, Piper Jaffray |
| CardioDx | CDX | IPO | Withdrawn | Withdrawn | 0/0/0 | Jefferies, Piper Jaffray |
| CareDx Inc., | CDNA | IPO | $15.00-$17.00 | 4 million | 7/17/2014 | Piper Jaffray, Leerink Partners |
| Cibus Ltd. | CBUS | IPO | Postponed | Postponed | 0/0/0 | Morgan Stanley, BofA Merrill Lynch, Piper Jaffray |
| Collegium Pharmaceutical | COLL | IPO | $12.00-$14.00 | 5.8 million | 5/7/2015 | Jefferies, Piper Jaffray |
| Colucid Pharmaceuticals | CLCD | IPO | $13.00-$15.00 | 5.5 million | 5/6/2015 | Piper Jaffray, Stifel |
| Conatus Pharmaceuticals | CNAT | IPO | $10.00-$12.00 | 6 million | 7/25/2013 | Stifel Nicolaus Weisel, Piper Jaffray |
| Coskata, Inc. | COSK | IPO | TBD | TBD | 0/0/0 | Citigroup, Barclays Capital, Piper Jaffray |
| Coty | COTY | IPO | $16.50-$18.50 | 57 million | 6/13/2013 | BofA Merrill Lynch, J.P. Morgan, Morgan Stanley, Barclays Capital, Deutsche Bank Securities, Wells Fargo Securities, Lazard Capital Markets, Piper Jaffray, RBC Capital Markets |
| Crinetics Pharmaceuticals, Inc. | CRNX | IPO | $15.00-$17.00 | 6.0 million | 7/18/2018 | J.P. Morgan, Leerink Partners, Piper Jaffray |
| CRISPR Therapeutics | CRSP | IPO | $15.00-$17.00 | 4 million | 10/19/2016 | Citigroup, Piper Jaffray, Barclays |
| Dave & Busters Entertainment, Inc. | PLAY | IPO | Priced at $16.00 | 5.9 million | 10/10/2014 | Jefferies, Piper Jaffray |
| Deciphera Pharmaceuticals | DCPH | IPO | $15.00-$17.00 | 7.5 million | 9/28/2017 | J.P. Morgan, Piper Jaffray |
| Del Frisco's Restaurant Group | DFRG | IPO | $14.00-$16.00 | 5.8 million | 7/27/2012 | Deutsche Bank Securities, Piper Jaffray, Wells Fargo Securities |
| DTLR Holding | DTLR | IPO | $12.00-$14.00 | 5.8 million | 12/12/2013 | Baird, Piper Jaffray |
| e.l.f. Beauty, Inc. | ELF | IPO | $14.00-$16.00 | 8.3 million | 9/22/2016 | J.P. Morgan, Morgan Stanley, Piper Jaffray, Wells Fargo Securities |
| Eagle Pharmaceuticals | EGRX | IPO | $14.00-$16.00 | 3.33 million | 2/12/2014 | Piper Jaffray, William Blair |
| Elevance Renewable Sciences, Inc. | ERSI | IPO | TBD | TBD | 0/0/0 | Morgan Stanley, J.P. Morgan, Jefferies, Piper Jaffray, Raymond James |
| Ellipse Technologies, Inc. | MGEC | IPO | TBD | TBD | 0/0/0 | Piper Jaffray, William Blair, Canaccord Genuity
|
| Entellus Medical | ENTL | IPO | $15.00-$17.00 | 4.6 million | 1/29/2015 | BofA Merrill Lynch, Piper Jaffray
|
| Flex Pharma | FLKS | IPO | $12.00-$14.00 | 5.4 million | 1/29/2015 | Jefferies, Piper Jaffray |
| Fox Factory Holding Corp. | FOXF | IPO | $13.00-$15.00 | 8.57 million | 8/8/2013 | Baird, William Blair, Piper Jaffray |
| Fulgent Genetics, Inc. | FLGT | IPO | $12.00-$14.00 | 4.2 million | 9/29/2016 | Credit Suisse, Piper Jaffray, Raymond James |
| GDC Technology Ltd | GDCT | IPO | $12.00-$14.00 | 5.8 million | 0/0/0 | Barclays Capital, Jefferies, Piper Jaffray |
| Gelesis, Inc. | GLSS | IPO | $12.00-$14.00 | 4 million | 0/0/0 | Piper Jaffray, Stifel, Guggenheim Securities |
| Gevo, Inc. | GEVO | IPO | Last trade $8.77 | 6.8 million | 6/29/2012 | UBS Investment Bank, Piper Jaffray |
| Globus Medical | GMED | IPO | $16.00-$18.00 | 8.33 million | 8/3/2012 | BofA Merrill Lynch, Goldman Sachs, Piper Jaffray |
| Glori Energy Inc. | GLRI | IPO | TBD | TBD | 0/0/0 | Credit Suisse, UBS Investment Bank, Piper Jaffray |
| IGM Biosciences, Inc. | IGMS | IPO | $15.00-$17.00 | 10.9 million | 9/18/2019 | Jefferies, Piper Jaffray, Stifel, Guggenheim Securities |
| Ignite Restaurant Group, Inc. | IRG | IPO | $12.00-$14.00 | 5.77 million | 5/11/2012 | Credit Suisse Securities, Baird, Piper Jaffray
|
| Impinj, Inc. | PI | IPO | $12.00-$14.00 | 4.8 million | 7/21/2016 | RBC Capital Markets, Pacific Crest Securities, Piper Jaffray |
| Imprivata, Inc. | IMPR | IPO | $14.00-$16.00 | 5 million | 6/25/2014 | J.P. Morgan, Piper Jaffray |
| Innocoll GmbH | INNL | IPO | $13.00-$15.00 | 6.3 million | 7/25/2014 | Piper Jaffray, Stifel |
| Inotek Pharmaceuticals Corporation | ITEK | IPO | $13.00-$15.00 | 6.67 million | 2/18/2015 | Cowen & Co., Piper Jaffray
|
| Intersect ENT, Inc. | XENT | IPO | $11.00-$13.00 | 5 milion | 7/24/2014 | J.P. Morgan, Piper Jaffray |
| Invuity, Inc. | IVTY | IPO | $14.00-$16.00 | 4 million | 6/15/2015 | Piper Jaffray, Leerink Partners, Stifel |
| K2M Group Holdings, Inc. | KTWO | IPO | $16.00-$18.00 | 8.83 million | 5/8/2014 | Piper Jaffray, Barclays, Wells Fargo Securities
|
| LDR Holding | LDRH | IPO | $14.00-$16.00 | 5 million | 10/9/2013 | Piper Jaffray, William Blair |
| Liposcience, Inc. | LPDX | IPO | $13.00-$15.00 | 5 million | 1/25/2013 | Barclays Capital, UBS Investment Bank, Piper Jaffray |
| Luca Technologies, Inc. | LUCA | IPO | $11.00-$13.00 | 8.5 million | 0/0/0 | Citigroup, Piper Jaffray, Raymond James |
| Marrone Bio Innovations | MBII | IPO | $14.00-$17.00 | 4.8 million | 8/2/2013 | Jefferies, Piper Jaffray |
| Materialise NV | MTLS | IPO | $12.00-$14.00 | 8 million | 6/25/2014 | Piper Jaffray, Credit Suisse |
| Menlo Therapeutics, Inc. | MNLO | IPO | $14.00-$16.00 | 7 million | 1/25/2018 | Jefferies, Piper Jaffray, Guggenheim Securities |
| Milestone Pharmaceuticals Inc. | MIST | IPO | $14.00-$16.00 | 5.5 million | 5/9/2019 | Jefferies, Cowen, Piper Jaffray, Oppenheimer & Co. |
| Moderna, Inc. | MRNA | IPO | $22.00-$24.00 | 26 million | 12/7/2018 | Morgan Stanley, Goldman Sachs & Co., J.P. Morgan, BofA Merrill Lynch, Barclays, Piper Jaffray |
| Motus GI Holdings, Inc. | MOTS | IPO | $5.00-$7.00 | 3.5 million | 2/14/2018 | Piper Jaffray, Oppenheimer & Co. |
| Myriant Corporation | MYRT | IPO | TBD | TBD | 0/0/0 | UBS Investment Bank, J.P. Morgan, Citigroup, Piper Jaffray |
| NantKwest | NK | IPO | $20.00-$23.00 | 8.3 million | 7/28/2015 | BofA Merrill Lynch, Citigroup, Jefferies, Piper Jaffray |
| Natera, Inc. | NTRA | IPO | $15.00-$17.00 | 10 million | 7/2/2015 | Morgan Stanley, Cowen & Co., Piper Jaffray |
| Natural Grocers by Vitamin Cottage | NGVC | IPO | $13.00-$15.00 | 7.14 million | 7/25/2012 | SunTrust Robinson Humphrey, Piper Jaffray |
| Neff Corporation | NEFF | IPO | $20.00-$22.00 | 10.5 million | 11/21/2014 | Morgan Stanley, Jefferies, Piper Jaffray |
| Neothetics, Inc. | NEOT | IPO | $13.00-$15.00 | 4.65 million | 11/20/2014 | Piper Jaffray, Guggenheim Securities
|
| NetQin Mobile | NQ | IPO | Priced at $11.50 | 7.75 million | 5/5/2011 | Piper Jaffray |
| Neuronetics, Inc. | STIM | IPO | $14.00-$16.00 | 5.5 million | 6/28/2018 | Piper Jaffray, William Blair |
| Newgistics, Inc. | NEWG | IPO | TBD | TBD | 0/0/0 | Stifel Nicolaus Weisel, Piper Jaffray
|
| Nexsan | NXSN | IPO | TBD | TBD | 0/0/0 | Piper Jaffray |
| NextCure, Inc. | NXTC | IPO | $14.00-$16.00 | 5 million | 5/9/2019 | Morgan Stanley, BofA Merrill Lynch, Piper Jaffray |
| Novan, Inc. | NOVN | IPO | $11.00-$13.00 | 4.1 million | 9/21/2016 | Piper Jaffray |
| Optinose, Inc. | OPTN | IPO | $15.00-$17.00 | 7.5 million | 10/13/2017 | Jefferies, Piper Jaffray, BMO Capital Markets, RBC Capital Markets |
| OrthoPediatrics Corp. | KIDS | IPO | $12.00-$14.00 | 4 million | 10/12/2017 | Piper Jaffray, Stifel |
| Oxford Immunotec Global PLC | OXFD | IPO | $13.00-$15.00 | 5.36 million | 11/22/2013 | J.P. Morgan, Piper Jaffray |
| Oyster Point Pharma, Inc | OYST | IPO | $16.00-$18.00 | 5 million | 10/31/2019 | JP Morgan, Cowen, Piper Jaffray |
| Parnell Pharmaceutical Holdings Ltd | PARN | IPO | $10.00-$10.00 | 5 million | 6/18/2014 | Jefferies, Piper Jaffray |
| Phreesia, Inc. | PHR | IPO | $15.00-$17.00 | 9.3 million | 7/18/2019 | JP Morgan, Wells Fargo Securities, William Blair, Allen & Co., Piper Jaffray |
| Proto Labs | PRLB | IPO | $13.00-$15.00 | 4.3 million | 2/24/2012 | Jefferies, Piper Jaffray |
| Ra Medical Systems, Inc. | RMED | IPO | $14.00-$16.00 | 3.9 million | 9/27/2018 | Piper Jaffray, Cantor |
| Rally Software Development Corp. | RALY | IPO | $11.00-$13.00 | 6 million | 4/12/2013 | Deutsche Bank Securities, Piper Jaffray |
| Reata Pharmaceuticals | RETA | IPO | $14.00-$16.00 | 5.5 million | 5/26/2016 | Citigroup, Cowen & Co., Piper Jaffray |
| REGENXBIO, Inc. | RGNX | IPO | $17.00-$19.00 | 6.3 million | 9/17/2015 | Morgan Stanley, BofA Merrill Lynch, Piper Jaffray |
| Renewable Energy Group | REGI | IPO | $13.00-$15.00 | 7.2 million | 1/19/2012 | UBS Investment Bank, Piper Jaffray |
| Reply! | RPLY | IPO | TBD | TBD | 0/0/0 | Jefferies, Piper Jaffray |
| Revance Therapeutics, Inc. | RVNC | IPO | $14.00-$16.00 | 6 million | 2/6/2014 | Cowen & Co., Piper Jaffray |
| rEVO Biologics, Inc. | RBIO | IPO | $13.00-$15.00 | 3.6 million | 0/0/0 | Piper Jaffray, Guggenheim Securities |
| Sancilio Pharmaceuticals | SPCI | IPO | TBD | TBD | 0/0/0 | UBS Investment Bank, Piper Jaffray |
| Sientra, Inc. | SIEN | IPO | $14.00-$16.00 | 5 million | 10/29/2014 | Piper Jaffray, Stifel
|
| Singulex | SGLX | IPO | $15.00-$17.00 | 4.4 million | 0/0/0 | UBS Investment Bank, Piper Jaffray |
| SurgiQuest, Inc. | TBD | IPO | TBD | TBD | 0/0/0 | Piper Jaffray, Stifel, Canaccord Genuity |
| Sutro Biopharma, Inc. | STRO | IPO | $14.00-$16.00 | 5.667 million | 9/27/2018 | Cowen, Piper Jaffray |
| Syros Pharmaceuticals | SYRS | IPO | $14.00-$16.00 | 4 million | 6/30/2016 | Cowen & Co., Piper Jaffray |
| Tabula Rasa HealthCare | TRHC | IPO | $13.00-$15.00 | 4.3 million | 9/29/2016 | Wells Fargo Securities, UBS Investment Bank, Piper Jaffray |
| Tactile Systems Technology | TCMD | IPO | $14.00-$16.00 | 4 million | 7/28/2016 | Piper Jaffray, William Blair, Canaccord Genuity |
| Tandem Diabetes Care | TNDM | IPO | $13.00-$15.00 | 8.0 million | 11/14/2013 | BofA Merrill Lynch, Piper Jaffray |
| TCP International Holdings Ltd. | TCPI | IPO | $13.00-$15.00 | 7.1 million | 6/26/2014 | Deutsche Bank Securities, Piper Jaffray |
| TELA Bio, Inc. | TELA | IPO | $14.00-$16.00 | 4 million | 11/8/2019 | Jefferies, Piper Jaffray, Canaccord Genuity |
| The Habit Restaurants | HABT | IPO | $14.00-$16.00 | 5 million | 11/20/2014 | Piper Jaffray, Baird, Wells Fargo Securities |
| Tilly's, Inc. | TLYS | IPO | Priced at $15.50 | 8 million | 5/4/2012 | Goldman Sachs, BofA Merrill Lynch, Piper Jaffray |
| uniQure B.V. | QURE | IPO | $13.00-$15.00 | 5.4 million | 2/5/2014 | Jefferies, Leerink Swann, Piper Jaffray |
| Valeritas, Inc | VLRX | IPO | $14.00-$16.00 | 5 million | 0/0/0 | Piper Jaffray, Leerink Partners
|
| Virobay, Inc. | VBAY | IPO | Withdrawn | 3.8 million | 0/0/0 | Piper Jaffray, JMP Securities, |
| Vocera Communications | VCRA | IPO | $12.00-$14.00 | 5.85 million | 3/28/2012 | J.P. Morgan, Piper Jaffray |
| Voxeljet AG | VJET | IPO | $13.00-$15.00 | 6.5 million | 10/18/2013 | Piper Jaffray, Citigroup |
| Voyager Therapeutics | VYGR | IPO | $15.00-$17.00 | 5 million | 11/11/2015 | Cowen & Co., Piper Jaffray, Nomura, Wedbush PacGrow |
| vTv Therapeutics Inc. | VTVT | IPO | $15.00-$17.00 | 7.8 million | 7/30/2015 | Piper Jaffray, Stifel |
| Yodle, Inc. | YO | IPO | TBD | TBD | 0/0/0 | Credit Suisse, Deutsche Bank Securities, Jefferies, Piper Jaffray |
| Zoe's Kitchen, Inc. | ZOES | IPO | $13.00-$15.00 | 5.8 million | 4/11/2014 | Jefferies, Piper Jaffray, Baird |
| Zynerba Pharmaceuticals, Inc. | ZYNE | IPO | $13.00-$15.00 | 3 million | 8/5/2015 | Jefferies, Piper Jaffray |
© 2005 - 2024 IPO Boutique. All Rights Reserved